Assignee
MSN LABORATORIES PRIVATE LTD
IN·12 granted patents·2 pending applications·17 citations·filing 2014–2018
Top patents by PatentIndex Score
14 records- 0188US10301302B2Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereofMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted May 28, 2019·14 cites·18 claims
- 0283US10550107B2Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Feb 4, 2020·3 cites·20 claims
- 0359US10544097B2Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereofMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Jan 28, 2020·0 cites·6 claims
- 0455US2019144411A1Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereofMSN LABORATORIES PRIVATE LTD·Filed 2018·Application pending·0 cites
- 0545US10633390B2Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous formMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Apr 28, 2020·0 cites·18 claims
- 0644US11279696B2Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-oneMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Mar 22, 2022·0 cites·4 claims
- 0740US10913762B2Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Feb 9, 2021·0 cites·17 claims
- 0840US2016237066A1Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonateMSN LABORATORIES PRIVATE LTD·Filed 2014·Application pending·0 cites
- 0937US10633372B2Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Apr 28, 2020·0 cites·11 claims
- 1035US10144710B2Process for the preparation of 4-[-({[4-choloro-3(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2015·Granted Dec 4, 2018·0 cites·11 claims
- 1134US10093625B2Process for the preparation of [[2(S)-[[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid dihydrateMSN LABORATORIES PRIVATE LTD·Filed 2015·Granted Oct 9, 2018·0 cites·13 claims
- 1233US10703731B2Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Jul 7, 2020·0 cites·12 claims
- 1333US10351556B2Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamateMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Jul 16, 2019·0 cites·16 claims
- 1432US10544189B2Process for the preparation of (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamideMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Jan 28, 2020·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when MSN LABORATORIES PRIVATE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →